Clinical Trial

Quality of Life Assessment of Caregivers of Patients With Multiple Myeloma

Study acronym: ENTRAIDANT
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The diagnosis and treatment of multiple myeloma affect not only the patient but also their family and caregivers. Advances in therapy have transformed the follow-up of patients treated for multiple myeloma. The involvement of informal caregivers has become increasingly essential to ensure adequate home-based care, as most treatments are now delivered on an outpatient basis. Literature reviews suggest that caregivers of cancer patients often face unmet supportive care needs, which in turn negatively impact their quality of life.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-28.
Trial Details
NCT Number NCT07276230
Lead Sponsor Assistance Publique - Hôpitaux de Paris
Conditions Caregivers of Patients With Multiple Myeloma
Enrollment 27 participants
Start Date 2026-02-01
Primary Completion 2027-05-01 (estimated)
Study Completion 2027-11-01 (estimated)
Updated on ClinicalTrials.gov 2025-12-29